| Market Cap | 93.03M |
| Revenue (ttm) | 71,619 |
| Net Income (ttm) | -1.01M |
| Shares Out | 21.00M |
| EPS (ttm) | -0.06 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,215 |
| Open | 4.550 |
| Previous Close | 4.330 |
| Day's Range | 4.400 - 4.590 |
| 52-Week Range | 3.510 - 6.720 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About CUPR
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste; and products using m... [Read more]
Financial Performance
In 2023, CUPR's revenue was 100,773, an increase of 78.05% compared to the previous year's 56,599. Losses were -1.12 million, 2.29% more than in 2022.
Financial numbers in SGD Financial StatementsNews
Cuprina Holdings Announces Closing of Underwriter's Over-Allotment Option in Connection with Initial Public Offering
SINGAPORE, May 08, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical and biotechnology company dedicated to the development and comme...
Cuprina Holdings Announces Completion, Receipt of Certification and License, for IVF Media Production Facility Built in Collaboration with Ferti-Craft Pte Ltd.
SINGAPORE, May 05, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical and biotechnology company dedicated to the development and comme...
Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering
SINGAPORE, May 05, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“CUPR” or “the Company”), a biomedical and biotechnology company dedicated to the development and commerci...
Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering
SINGAPORE, May 05, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (“CUPR” or “the Company”), a biomedical and biotechnology company dedicated to the development and commercialization of pr...
U.S. IPO Weekly Recap: Flurry Of Small Issuers List, Despite Heightened Market Volatility
Seven IPOs and one SPAC debuted this week. One IPO and three SPACs submitted initial filings. Two sizable deals are set to lead the IPO calendar in the coming week.
Singapore-based Cuprina Holdings, which makes wound care products, files for a $10 million US IPO
Cuprina Holdings, a Singapore-based provider of chronic wound care products, filed on Thursday with the SEC to raise up to $10 million in an initial public offering.
Cuprina Holdings IPO Registration Document (F-1)
Cuprina Holdings has filed to go public with an IPO on the NASDAQ.